Liberia: WHO Africa Chief Janabi Urges Science-Led

**HEADLINE:** Liberia Healthcare Modernization: WHO Africa Chief's Science-Led Investment Plan for 2025

**META_DESCRIPTION:** WHO Africa Chief Janabi urges Liberia to adopt science-led health investment and security reforms. What investors need to know about healthcare sector opportunities.

---

## ARTICLE:

Liberia stands at a critical juncture in its health sector development. Dr. Matshidiso Moeti, WHO Africa Regional Director, has publicly urged Liberian policymakers to anchor future health investments in scientific evidence rather than reactive crisis management—a call that signals both the region's vulnerability and its potential for institutional transformation.

Liberia's health system remains fragile, shaped by decades of conflict and chronic underfunding. The country's healthcare expenditure hovers below 5% of GDP, far short of the African Union's Abuja Declaration target of 15%. Life expectancy at birth (63 years) trails the African average, and maternal mortality ratios persist at levels that constrain workforce productivity and economic growth. For investors and development partners, these metrics underscore why health system resilience is now a macro-economic priority, not merely a humanitarian concern.

## Why is science-led health investment critical for Liberia's economy?

The WHO Africa Chief's emphasis on data-driven planning reflects a hard lesson: ad-hoc spending on health crises—whether pandemic response or disease outbreaks—diverts capital from prevention and infrastructure. Liberia's experience with Ebola (2014–2016) revealed how weak laboratory networks, fragmented supply chains, and lack of epidemiological surveillance capacity turned a regional crisis into a national economic catastrophe. Rebuilding requires sustained, evidence-based investment in:

- **Diagnostic infrastructure**: Real-time pathogen detection and disease surveillance systems
- **Health workforce development**: Training facilities and retention mechanisms for clinicians and technicians
- **Cold-chain and pharmaceutical logistics**: Critical for vaccine coverage and drug accessibility
- **Cybersecurity and data systems**: Essential for secure health records and outbreak tracking

The WHO's push aligns with Liberia's own National Health Policy (2016–2021, now extended), which acknowledges these gaps. However, implementation has lagged due to constrained public budgets and competing priorities.

## What security measures strengthen health sector resilience?

Health facility security—often overlooked—directly impacts service delivery. Liberia's remote clinics face risks from armed banditry, theft of pharmaceuticals and equipment, and supply-chain disruption. The WHO's call for integrated security planning means linking border health surveillance with customs enforcement, strengthening facility access controls, and coordinating with regional health bodies to prevent disease smuggling and counterfeit drug infiltration. This infrastructure also creates employment opportunities and improves trust in public health systems.

## How can investors capitalize on Liberia's health modernization drive?

Foreign and diaspora investors now have entry points in medical device distribution, laboratory management services, health IT platforms, and public-private partnerships (PPPs) for facility construction and operation. Liberia's membership in regional trade blocs (ECOWAS, AfCFTA) creates pathways for regional healthcare supply chains. Donors and multilateral institutions (World Bank, African Development Bank, Global Fund) are increasingly channeling funds through performance-based contracts, creating opportunities for competent service providers.

The science-led framework also signals regulatory improvements ahead. Liberia is harmonizing pharmaceutical standards with ECOWAS protocols, a shift that raises barriers to entry (good) but rewards compliant suppliers (opportunity).

---

##